Ipercoagulabilità e recidiva di infarto cerebrale.

Translated title of the contribution: Hypercoagulation and recurrence of cerebral infarct

G. L. Landi, N. Anzalone, A. Morabito, A. D'Angelo, P. M. Mannucci

Research output: Contribution to journalArticlepeer-review


We measured plasma levels of fibrinopeptide A (FPA) and beta-thromboglobulin (BTG) in 27 patients, two months after first stroke. FPA, a sensitive index of "in vivo" hypercoagulability, was significantly higher in stroke patients than in 40 age- and sex-matched controls, and in patients with cerebral infarction who experienced recurrence within 5 years than in those who remained asymptomatic. On the contrary, FPA levels had no prognostic significance among patients with hemorrhagic stroke. Also BTG, an index of platelet activation, was higher in patients than in controls, but it was not associated with stroke recurrence. In a multivariate analysis of hemostatic and clinical variables, only FPA levels greater than 4 ng/ml were significantly related to cerebral reinfarction. These results support the role of hypercoagulability in the recurrence of ischemic stroke and allow identification of patients at high risk of cerebral reinfarction, providing a rationale for clinical trials of anticoagulant therapy in this subgroup.

Translated title of the contributionHypercoagulation and recurrence of cerebral infarct
Original languageItalian
Pages (from-to)415-416, 418
JournalGiornale di Clinica Medica
Issue number6-7
Publication statusPublished - Jun 1989

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Hypercoagulation and recurrence of cerebral infarct'. Together they form a unique fingerprint.

Cite this